Frontier is looking for a VP of Finance to serve as a strategic finance partner to the CFO and executive leadership team. This is a broad finance leadership role that combines strong FP&A leadership with genuine fluency in technical accounting and SEC reporting — the ideal candidate is as comfortable leading the annual budget cycle as they are working through a complex accounting memo or registration statement disclosure. The VP of Finance will work in conjunction with the Controller, providing senior-level financial oversight and support, including direct ownership of SEC reporting readiness and technical accounting matters as the company scales toward and through a public company structure.RequirementsWhat will you be doing?SEC Reporting & Technical AccountingOwn SEC reporting readiness and capital markets workstreams, drawing on prior experience with registration statements, periodic reporting (10-K/10-Q), or public company financial operations.Serve as a senior technical accounting resource in conjunction with the Controller, researching and documenting positions on complex or judgment-heavy accounting matters (revenue recognition, equity, leases, etc.).Lead SOX 404(a)/(b) readiness from a planning and controls-design perspective, partnering with the Controller to build out the control environment ahead of public company requirements.Build out investor-facing financial materials, messaging, and disclosure language in close coordination with the CFO.Support capital markets transactions (equity/debt offerings, registration statements) as they arise, including coordination with underwriters, auditors, and outside counsel.FP&A & Business PartnershipLead annual budgeting, long-range planning, monthly forecasting, and variance analysis across all departments, with strong financial modeling as a core skill.Serve as a strategic financial business partner to R&D, Clinical, Regulatory, Medical, and G&A leaders, translating program and headcount plans into financial models.Build and maintain financial models supporting capital planning, cash runway analysis, and scenario planning for the Board and investors.Lead clinical trial and R&D accrual forecasting in partnership with the Controller and Clinical Development teams.Partner closely with the CFO on Board presentations, investor materials, and strategic planning; prepare Board-level financial reporting packages and actual-to-budget analyses.Drive finance systems and process improvements (planning tools, reporting automation) to scale the finance organization as the company grows.Provide ad hoc financial analysis and special project support to the CFO.What are we looking for?Bachelor's degree in Finance or Accounting required; CPA strongly preferred given the technical accounting and SEC reporting scope of this role. MBA a plus.15+ years of progressive finance experience, with a genuine dual fluency: strong FP&A/financial modeling skills AND hands-on technical accounting and SEC reporting experience — not just exposure to one side.Big Four public accounting background strongly preferred, ideally followed by industry experience at a biotech/life sciences company that scaled through significant growth (clinical-stage to commercial, or private to public).Direct, hands-on experience with SEC reporting cycles (10-K/10-Q), registration statements, and/or public company financial operations required.Experience with capital markets transactions and working alongside underwriters, external auditors, and outside counsel strongly preferred.Comfortable working in conjunction with a Controller and accounting team as part of a broader finance leadership structure — this role adds senior technical depth, not a duplicate accounting function.Clinical trial accounting and biotech/therapeutics industry experience preferred.Excellent communication skills, with the ability to translate financial and accounting detail into clear guidance for non-finance executives.BenefitsHealth Care Plan (Medical, Dental & Vision)Retirement Plan (401k, IRA)Life Insurance (Basic, Voluntary & AD&D)Paid Time Off (Vacation, Sick & Public Holidays)Family Leave (Maternity, Paternity)Short Term & Long Term DisabilityTraining & DevelopmentFree Food & SnacksWellness ResourcesStock Option PlanAt Frontier, we strive to build a diverse and equitable workplace. The salary range for this role is $250,000 to $310,000. Compensation for the role will depend on a number of factors, including candidates' qualifications, skills, competencies and experience. Frontier offers a competitive total rewards package which includes healthcare coverage, 401k and a broad range of other benefits. This compensation and benefits information is based on Frontier's knowledge as of the date of publication, and may be modified in the future.
Frontier is looking for a VP of Finance to serve as a strategic finance partner to the CFO and executive leadership team. This is a broad finance leadership role that combines strong FP&A leadership with genuine fluency in technical accounting and SEC reporting — the ideal candidate is as comfortable leading the annual budget cycle as they are working through a complex accounting memo or registration statement disclosure. The VP of Finance will work in conjunction with the Controller, providing senior-level financial oversight and support, including direct ownership of SEC reporting readiness and technical accounting matters as the company scales toward and through a public company structure.
Requirements
What will you be doing?
SEC Reporting & Technical Accounting
- Own SEC reporting readiness and capital markets workstreams, drawing on prior experience with registration statements, periodic reporting (10-K/10-Q), or public company financial operations.
- Serve as a senior technical accounting resource in conjunction with the Controller, researching and documenting positions on complex or judgment-heavy accounting matters (revenue recognition, equity, leases, etc.).
- Lead SOX 404(a)/(b) readiness from a planning and controls-design perspective, partnering with the Controller to build out the control environment ahead of public company requirements.
- Build out investor-facing financial materials, messaging, and disclosure language in close coordination with the CFO.
- Support capital markets transactions (equity/debt offerings, registration statements) as they arise, including coordination with underwriters, auditors, and outside counsel.
FP&A & Business Partnership
- Lead annual budgeting, long-range planning, monthly forecasting, and variance analysis across all departments, with strong financial modeling as a core skill.
- Serve as a strategic financial business partner to R&D, Clinical, Regulatory, Medical, and G&A leaders, translating program and headcount plans into financial models.
- Build and maintain financial models supporting capital planning, cash runway analysis, and scenario planning for the Board and investors.
- Lead clinical trial and R&D accrual forecasting in partnership with the Controller and Clinical Development teams.
- Partner closely with the CFO on Board presentations, investor materials, and strategic planning; prepare Board-level financial reporting packages and actual-to-budget analyses.
- Drive finance systems and process improvements (planning tools, reporting automation) to scale the finance organization as the company grows.
- Provide ad hoc financial analysis and special project support to the CFO.
What are we looking for?
- Bachelor's degree in Finance or Accounting required; CPA strongly preferred given the technical accounting and SEC reporting scope of this role. MBA a plus.
- 15+ years of progressive finance experience, with a genuine dual fluency: strong FP&A/financial modeling skills AND hands-on technical accounting and SEC reporting experience — not just exposure to one side.
- Big Four public accounting background strongly preferred, ideally followed by industry experience at a biotech/life sciences company that scaled through significant growth (clinical-stage to commercial, or private to public).
- Direct, hands-on experience with SEC reporting cycles (10-K/10-Q), registration statements, and/or public company financial operations required.
- Experience with capital markets transactions and working alongside underwriters, external auditors, and outside counsel strongly preferred.
- Comfortable working in conjunction with a Controller and accounting team as part of a broader finance leadership structure — this role adds senior technical depth, not a duplicate accounting function.
- Clinical trial accounting and biotech/therapeutics industry experience preferred.
- Excellent communication skills, with the ability to translate financial and accounting detail into clear guidance for non-finance executives.
Benefits
- Health Care Plan (Medical, Dental & Vision)
- Retirement Plan (401k, IRA)
- Life Insurance (Basic, Voluntary & AD&D)
- Paid Time Off (Vacation, Sick & Public Holidays)
- Family Leave (Maternity, Paternity)
- Short Term & Long Term Disability
- Training & Development
- Free Food & Snacks
- Wellness Resources
- Stock Option Plan
At Frontier, we strive to build a diverse and equitable workplace. The salary range for this role is $250,000 to $310,000. Compensation for the role will depend on a number of factors, including candidates' qualifications, skills, competencies and experience. Frontier offers a competitive total rewards package which includes healthcare coverage, 401k and a broad range of other benefits.
This compensation and benefits information is based on Frontier's knowledge as of the date of publication, and may be modified in the future.
Frontier Medicines is a pre-clinical stage biopharmaceutical company that is pioneering breakthrough technologies to drug the “undruggable” proteome. Frontier Medicines’ proprietary platform uses chemoproteomics – an innovative approach to chemically interrogate proteins in living systems – to discover and pharmacologically target new binding pockets (or hotspots) on proteins for the purpose of making them accessible to therapeutic intervention. Our therapeutic programs are focused on some of the most important and difficult targets in human disease, starting with cancer, in order to change the lives of patients for the better. As a Fierce 15 company FierceBiotech recognized Frontier as one of the most promising private biotechnology companies in the industry.
Frontier Medicines is a pre-clinical stage biopharmaceutical company that is pioneering breakthrough technologies to drug the “undruggable” proteome. Frontier Medicines’ proprietary platform uses chemoproteomics – an innovative approach to chemically interrogate proteins in living systems – to discover and pharmacologically target new binding pockets (or hotspots) on proteins for the purpose of making them accessible to therapeutic intervention. Our therapeutic programs are focused on some of the most important and difficult targets in human disease, starting with cancer, in order to change the lives of patients for the better. As a Fierce 15 company FierceBiotech recognized Frontier as one of the most promising private biotechnology companies in the industry.
